Previous close | 142.32 |
Open | 143.90 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 143.71 - 145.69 |
52-week range | 143.66 - 217.98 |
Volume | |
Avg. volume | 1,441 |
Market cap | 166.709M |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
It hasn't been the best quarter for Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) shareholders, since the share price...